(Q39052473)

8 September 2017

miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3. (English)

1 reference

8 September 2017

endometrial carcinoma

1 reference

Yunyun Li

1

1 reference

8 September 2017

Zhongzu Zhang

2

1 reference

8 September 2017

Xiuxia Liu

3

1 reference

8 September 2017

Tingting Huang

4

1 reference

8 September 2017

Wenfeng He

5

1 reference

8 September 2017

Yang Shen

6

1 reference

8 September 2017

Xin Liu

7

1 reference

8 September 2017

Kui Hong

8

1 reference

8 September 2017

Qing Cao

9

1 reference

8 September 2017

28 November 2013

1 reference

Molecular and Cellular Biochemistry

8 September 2017

1 reference

8 September 2017

388

1 reference

8 September 2017

1-2

1 reference

8 September 2017

219-231

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1913-2

8 September 2017

0 references

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Pharmacotherapy of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

MicroRNAs in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

MicroRNAs: an emerging science in cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

The miR-17 ∼ 92 Cluster: A Key Player in the Control of Inflammation during Rheumatoid Arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

STAT3 down-regulates the expression of cyclin D during liver development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Targeting liver cancer: first steps toward a miRacle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Breast cancer and microRNAs: therapeutic impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Stat3 activation in human endometrial and cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

Expression of miR-124 inhibits growth of medulloblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1913-2

microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs

21 January 2018

1 reference

12 December 2020

[Abnormal expression of microRNA-124 in patients with leukemia or myelodysplastic syndrome and its significance]

1 reference

12 December 2020

Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer

1 reference

12 December 2020

MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2

1 reference

12 December 2020

MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).

1 reference

12 December 2020

Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells

1 reference

12 December 2020

10.1007/S11010-013-1913-2

Identifiers

DOI

1 reference

8 September 2017

1 reference